Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.35 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MITF | O75030 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29670059 | 0.83 | AHR (0.42) | AHRPIN1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL24270381 | 0.83 | AHR (0.42) | AHRPIN1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL22249688 | 0.78 | AHR (0.38) | AHRLMNAPPARGNCOA2NPSR1 | |
| SCHEMBL22249796 | 0.74 | KDM4E (0.36) | AHRLMNAPPARGNCOA2NPSR1 | |
| SCHEMBL22249798 | 0.70 | KMT2A (0.42) | AHRALDH2KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL22250026 | 0.70 | IDO1 (0.39) | AHRALDH2KDM4EALDH1A1MEN1 | |
| SCHEMBL16225041 | 0.66 | ALDH1A1 (0.40) | LMNAPIN1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL22249681 | 0.66 | MAPT (0.30) | MAPT | |
| SCHEMBL22249686 | 0.66 | AHR (0.63) | AHRLMNAALDH2KDM4EALDH1A1 | |
| SCHEMBL24039795 | 0.66 | AHR (0.63) | AHRLMNAALDH2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200235306-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200235306-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | OR10J3, PIEZO1, ODC1 | AHR 2547/4885LMNA 2474/4885PPARG 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.